• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性肺泡损伤和血栓性微血管病是 COVID-19 患者肺组织活检样本中的主要组织病理学发现。

Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.

机构信息

Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Pathol Res Pract. 2020 Oct;216(10):153228. doi: 10.1016/j.prp.2020.153228. Epub 2020 Sep 19.

DOI:10.1016/j.prp.2020.153228
PMID:32979740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837112/
Abstract

BACKGROUND

Since the outbreak of the novel coronavirus disease-2019 (COVID-19) in December 2019, limited studies have investigated the histopathologic findings of patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

MATERIAL AND METHODS

This study was conducted on 31 deceased patients who were hospitalized for COVID-19 in a tertiary hospital in Tehran, Iran. A total of 52 postmortem tissue biopsy samples were obtained from the lungs and liver of decedents. Clinical characteristics, laboratory data, and microscopic features were evaluated. Reverse transcription polymerase chain reaction (RT-PCR) assay for SARS-CoV-2 was performed on specimens obtained from nasopharyngeal swabs and tissue biopsies.

RESULTS

The median age of deceased patients was 66 years (range, 30-87 years) and 25 decedents (81 %) were male. The average interval from symptom onset to death was 13 days (range, 6-34 days). On histopathologic examination of the lung specimens, diffuse alveolar damage and thrombotic microangiopathy were the most common findings (80 % and 60 %, respectively). Liver specimens mainly showed macrovesicular steatosis, portal lymphoplasmacytic inflammation and passive congestion. No definitive viral inclusions were observed in any of the specimens. In addition, 92 % of lung tissue samples tested positive for SARS-CoV-2 by RT-PCR.

CONCLUSIONS

Further studies are needed to investigate whether SARS-CoV-2 causes direct cytopathic changes in various organs of the human body.

摘要

背景

自 2019 年 12 月新型冠状病毒病-2019(COVID-19)爆发以来,有限的研究调查了严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)感染患者的组织病理学发现。

材料和方法

本研究在伊朗德黑兰的一家三级医院对 31 名因 COVID-19 住院的已故患者进行,共从死者的肺部和肝脏获得 52 份尸检组织活检样本。评估了临床特征、实验室数据和显微镜特征。对从鼻咽拭子和组织活检获得的标本进行 SARS-CoV-2 的逆转录聚合酶链反应(RT-PCR)检测。

结果

已故患者的中位年龄为 66 岁(范围 30-87 岁),25 名患者(81%)为男性。从症状发作到死亡的平均间隔为 13 天(范围 6-34 天)。在肺标本的组织病理学检查中,弥漫性肺泡损伤和血栓性微血管病是最常见的发现(分别为 80%和 60%)。肝标本主要表现为大泡性脂肪变性、门脉淋巴浆细胞炎症和被动充血。在任何标本中均未观察到明确的病毒包涵体。此外,92%的肺组织样本通过 RT-PCR 检测 SARS-CoV-2 呈阳性。

结论

需要进一步研究以调查 SARS-CoV-2 是否会导致人体各种器官的直接细胞病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/5accc618a1d6/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/c9aa52aa1475/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/95911b54755c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/5accc618a1d6/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/c9aa52aa1475/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/95911b54755c/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/7837112/5accc618a1d6/gr3_lrg.jpg

相似文献

1
Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.弥漫性肺泡损伤和血栓性微血管病是 COVID-19 患者肺组织活检样本中的主要组织病理学发现。
Pathol Res Pract. 2020 Oct;216(10):153228. doi: 10.1016/j.prp.2020.153228. Epub 2020 Sep 19.
2
Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.COVID-19 致死病例的完整尸检数据:临床、影像学和病理学相关性。
Int J Legal Med. 2020 Nov;134(6):2209-2214. doi: 10.1007/s00414-020-02390-1. Epub 2020 Aug 6.
3
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.华盛顿州致命性 COVID-19 感染的组织病理学和超微结构发现:病例系列研究。
Lancet. 2020 Aug 1;396(10247):320-332. doi: 10.1016/S0140-6736(20)31305-2. Epub 2020 Jul 16.
4
COVID-19 Autopsies, Oklahoma, USA.美国俄克拉荷马州的 COVID-19 尸检。
Am J Clin Pathol. 2020 May 5;153(6):725-733. doi: 10.1093/ajcp/aqaa062.
5
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
6
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.新型冠状病毒疾病 2019 感染导致的弥漫性肺泡损伤(DAD)在形态上与其他 DAD 病因无法区分。
Histopathology. 2020 Oct;77(4):570-578. doi: 10.1111/his.14180. Epub 2020 Sep 12.
7
Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.德国首例 COVID-19 死亡病例:一名 59 岁男性,因 SARS-CoV-2 感染导致弥漫性肺泡损伤。
Virchows Arch. 2020 Sep;477(3):335-339. doi: 10.1007/s00428-020-02872-y. Epub 2020 Jul 4.
8
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.在 COVID-19 患者的肺部和呼吸道中原位检测 SARS-CoV-2。
Mod Pathol. 2020 Nov;33(11):2104-2114. doi: 10.1038/s41379-020-0595-z. Epub 2020 Jun 19.
9
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
10
Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.危重症 COVID-19 患者的晚期组织病理学特征:无侵袭性曲霉菌病证据的不同表型,一项病例系列研究。
J Crit Care. 2020 Oct;59:149-155. doi: 10.1016/j.jcrc.2020.07.002. Epub 2020 Jul 8.

引用本文的文献

1
Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023.2023年新冠病毒感染患者红细胞的形态与功能:当前概述
Life (Basel). 2024 Apr 1;14(4):460. doi: 10.3390/life14040460.
2
Cardio-Pulmonary Histopathology with Clinical Correlations of Deceased Patients with COVID-19: A Case Series in Tehran, Iran.COVID-19 死亡患者心肺组织病理学与临床相关性的病例系列研究:伊朗德黑兰的一项研究
Arch Iran Med. 2023 May 1;26(5):252-260. doi: 10.34172/aim.2023.39.
3
Effect of Respiratory Failure on Peripheral and Organ Perfusion Markers in Severe COVID-19: A Prospective Cohort Study.

本文引用的文献

1
A review of the main histopathological findings in coronavirus disease 2019.2019年冠状病毒病主要组织病理学发现综述
Hum Pathol. 2020 Nov;105:74-83. doi: 10.1016/j.humpath.2020.07.023. Epub 2020 Aug 2.
2
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染:一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
3
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
呼吸衰竭对重症新型冠状病毒肺炎患者外周及器官灌注标志物的影响:一项前瞻性队列研究
J Clin Med. 2024 Jan 15;13(2):469. doi: 10.3390/jcm13020469.
4
Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of strain infection.调节性 T 细胞、吲哚胺 2,3-双加氧酶和血红素加氧酶-1在肺部的有益或有害活性受菌株感染毒力水平的影响。
Front Cell Infect Microbiol. 2023 May 22;13:1105872. doi: 10.3389/fcimb.2023.1105872. eCollection 2023.
5
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan.对约旦一系列病例中新冠病毒肺炎患者进行的尸检肺和心脏检查。
J Pathol Transl Med. 2023 Mar;57(2):102-112. doi: 10.4132/jptm.2023.01.30. Epub 2023 Mar 14.
6
Life-threatening pneumothorax after release from isolation with COVID-19 pneumonia.新型冠状病毒肺炎解除隔离后出现危及生命的气胸。
Radiol Case Rep. 2023 Mar;18(3):903-906. doi: 10.1016/j.radcr.2022.11.075. Epub 2022 Dec 22.
7
Cerebral vascular injury in transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病中的脑血管损伤。
Blood Adv. 2022 Jul 26;6(14):4310-4319. doi: 10.1182/bloodadvances.2022007453.
8
Findings and inferences from full autopsies, minimally invasive autopsies and biopsy studies in patients who died as a result of COVID19 - A systematic review.COVID19 致死患者的全尸解剖、微创解剖和活检研究的结果和推论——一项系统综述。
Forensic Sci Med Pathol. 2022 Sep;18(3):369-381. doi: 10.1007/s12024-022-00494-1. Epub 2022 Jul 8.
9
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration.非危重症住院 COVID-19 患者在临床恶化时,其肺部受累和未受累节段之间的肺血管化存在差异,表现为微血管损伤、继发性水肿和不一致性。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221096040. doi: 10.1177/17534666221096040.
10
COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.欧洲国家与意大利的 COVID-19 医疗和药物管理比较:概述。
Int J Environ Res Public Health. 2022 Apr 2;19(7):4262. doi: 10.3390/ijerph19074262.
华盛顿州致命性 COVID-19 感染的组织病理学和超微结构发现:病例系列研究。
Lancet. 2020 Aug 1;396(10247):320-332. doi: 10.1016/S0140-6736(20)31305-2. Epub 2020 Jul 16.
4
Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD.慢性肾脏病患者中新型冠状病毒肺炎的临床和影像学特征
Iran J Kidney Dis. 2020 Jul;14(4):267-277.
5
Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings?新冠肺炎合并血糖控制良好与控制不佳的患者:其结局和影像学表现是否存在差异?
Diabetes Res Clin Pract. 2020 Aug;166:108286. doi: 10.1016/j.diabres.2020.108286. Epub 2020 Jun 25.
6
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
7
Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.在隔离期间,与 COVID-19 相关的死亡病例的大体和组织病理学肺部观察结果。
Int J Legal Med. 2020 Jul;134(4):1285-1290. doi: 10.1007/s00414-020-02319-8. Epub 2020 Jun 5.
8
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
9
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.非裔美国人 COVID-19 患者的肺部和心脏病理学:来自新奥尔良的尸检系列。
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
10
Electron microscopy of SARS-CoV-2: a challenging task.严重急性呼吸综合征冠状病毒2型的电子显微镜检查:一项具有挑战性的任务。
Lancet. 2020 May 30;395(10238):e99. doi: 10.1016/S0140-6736(20)31188-0. Epub 2020 May 19.